ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prokinetic Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27V8237
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Prokinetic Drug Market Insights and Forecast to 2028
BUY CHAPTERS

Global Prokinetic Drug Market Research Report 2025

Code: QYRE-Auto-27V8237
Report
July 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer Inc
TEVA
Cadila Pharmaceuticals
Hanmi Pharm
Johnson & Johnson

Prokinetic Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prokinetic Drug Market

Prokinetic Drug Market

The global market for Prokinetic Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prokinetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokinetic Drug.
The Prokinetic Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prokinetic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prokinetic Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prokinetic Drug Market Report

Report Metric Details
Report Name Prokinetic Drug Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prokinetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prokinetic Drug Market report?

Ans: The main players in the Prokinetic Drug Market are Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals, Hanmi Pharm

What are the Application segmentation covered in the Prokinetic Drug Market report?

Ans: The Applications covered in the Prokinetic Drug Market report are Gastroparesis, Constipation, Reflux Esophagitis, Functional Dyspepsia

What are the Type segmentation covered in the Prokinetic Drug Market report?

Ans: The Types covered in the Prokinetic Drug Market report are Metoclopramide, Domperidone, Cisapride, Others

Recommended Reports

Gastrointestinal Diseases

Digestive Drug Therapy

Therapeutic Trends

1 Prokinetic Drug Market Overview
1.1 Product Definition
1.2 Prokinetic Drug by Type
1.2.1 Global Prokinetic Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metoclopramide
1.2.3 Domperidone
1.2.4 Cisapride
1.2.5 Others
1.3 Prokinetic Drug by Application
1.3.1 Global Prokinetic Drug Market Value by Application (2024 VS 2031)
1.3.2 Gastroparesis
1.3.3 Constipation
1.3.4 Reflux Esophagitis
1.3.5 Functional Dyspepsia
1.4 Global Prokinetic Drug Market Size Estimates and Forecasts
1.4.1 Global Prokinetic Drug Revenue 2020-2031
1.4.2 Global Prokinetic Drug Sales 2020-2031
1.4.3 Global Prokinetic Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prokinetic Drug Market Competition by Manufacturers
2.1 Global Prokinetic Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prokinetic Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prokinetic Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prokinetic Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prokinetic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prokinetic Drug, Product Type & Application
2.7 Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry
2.8 Global Prokinetic Drug Market Competitive Situation and Trends
2.8.1 Global Prokinetic Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prokinetic Drug Players Market Share by Revenue
2.8.3 Global Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prokinetic Drug Market Scenario by Region
3.1 Global Prokinetic Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prokinetic Drug Sales by Region: 2020-2031
3.2.1 Global Prokinetic Drug Sales by Region: 2020-2025
3.2.2 Global Prokinetic Drug Sales by Region: 2026-2031
3.3 Global Prokinetic Drug Revenue by Region: 2020-2031
3.3.1 Global Prokinetic Drug Revenue by Region: 2020-2025
3.3.2 Global Prokinetic Drug Revenue by Region: 2026-2031
3.4 North America Prokinetic Drug Market Facts & Figures by Country
3.4.1 North America Prokinetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prokinetic Drug Sales by Country (2020-2031)
3.4.3 North America Prokinetic Drug Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prokinetic Drug Market Facts & Figures by Country
3.5.1 Europe Prokinetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prokinetic Drug Sales by Country (2020-2031)
3.5.3 Europe Prokinetic Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prokinetic Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Prokinetic Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prokinetic Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Prokinetic Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prokinetic Drug Market Facts & Figures by Country
3.7.1 Latin America Prokinetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prokinetic Drug Sales by Country (2020-2031)
3.7.3 Latin America Prokinetic Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prokinetic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prokinetic Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prokinetic Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prokinetic Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prokinetic Drug Sales by Type (2020-2031)
4.1.1 Global Prokinetic Drug Sales by Type (2020-2025)
4.1.2 Global Prokinetic Drug Sales by Type (2026-2031)
4.1.3 Global Prokinetic Drug Sales Market Share by Type (2020-2031)
4.2 Global Prokinetic Drug Revenue by Type (2020-2031)
4.2.1 Global Prokinetic Drug Revenue by Type (2020-2025)
4.2.2 Global Prokinetic Drug Revenue by Type (2026-2031)
4.2.3 Global Prokinetic Drug Revenue Market Share by Type (2020-2031)
4.3 Global Prokinetic Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prokinetic Drug Sales by Application (2020-2031)
5.1.1 Global Prokinetic Drug Sales by Application (2020-2025)
5.1.2 Global Prokinetic Drug Sales by Application (2026-2031)
5.1.3 Global Prokinetic Drug Sales Market Share by Application (2020-2031)
5.2 Global Prokinetic Drug Revenue by Application (2020-2031)
5.2.1 Global Prokinetic Drug Revenue by Application (2020-2025)
5.2.2 Global Prokinetic Drug Revenue by Application (2026-2031)
5.2.3 Global Prokinetic Drug Revenue Market Share by Application (2020-2031)
5.3 Global Prokinetic Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sumitomo
6.1.1 Sumitomo Company Information
6.1.2 Sumitomo Description and Business Overview
6.1.3 Sumitomo Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sumitomo Prokinetic Drug Product Portfolio
6.1.5 Sumitomo Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Prokinetic Drug Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Prokinetic Drug Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Kyowa Kirin Pharmaceuticals
6.4.1 Kyowa Kirin Pharmaceuticals Company Information
6.4.2 Kyowa Kirin Pharmaceuticals Description and Business Overview
6.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Portfolio
6.4.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Prokinetic Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Prokinetic Drug Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Cadila Pharmaceuticals
6.7.1 Cadila Pharmaceuticals Company Information
6.7.2 Cadila Pharmaceuticals Description and Business Overview
6.7.3 Cadila Pharmaceuticals Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cadila Pharmaceuticals Prokinetic Drug Product Portfolio
6.7.5 Cadila Pharmaceuticals Recent Developments/Updates
6.8 Hanmi Pharm
6.8.1 Hanmi Pharm Company Information
6.8.2 Hanmi Pharm Description and Business Overview
6.8.3 Hanmi Pharm Prokinetic Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hanmi Pharm Prokinetic Drug Product Portfolio
6.8.5 Hanmi Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prokinetic Drug Industry Chain Analysis
7.2 Prokinetic Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prokinetic Drug Production Mode & Process Analysis
7.4 Prokinetic Drug Sales and Marketing
7.4.1 Prokinetic Drug Sales Channels
7.4.2 Prokinetic Drug Distributors
7.5 Prokinetic Drug Customer Analysis
8 Prokinetic Drug Market Dynamics
8.1 Prokinetic Drug Industry Trends
8.2 Prokinetic Drug Market Drivers
8.3 Prokinetic Drug Market Challenges
8.4 Prokinetic Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer Inc
TEVA
Cadila Pharmaceuticals
Hanmi Pharm
Johnson & Johnson
List of Tables
 Table 1. Global Prokinetic Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prokinetic Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prokinetic Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prokinetic Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prokinetic Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prokinetic Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prokinetic Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prokinetic Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prokinetic Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prokinetic Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prokinetic Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Prokinetic Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prokinetic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prokinetic Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prokinetic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prokinetic Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prokinetic Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Prokinetic Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prokinetic Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Prokinetic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prokinetic Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Prokinetic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prokinetic Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Prokinetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prokinetic Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prokinetic Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prokinetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prokinetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prokinetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prokinetic Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prokinetic Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prokinetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prokinetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prokinetic Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prokinetic Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prokinetic Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prokinetic Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prokinetic Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prokinetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prokinetic Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prokinetic Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prokinetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prokinetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prokinetic Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prokinetic Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prokinetic Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prokinetic Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prokinetic Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prokinetic Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Prokinetic Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Prokinetic Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Prokinetic Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Prokinetic Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prokinetic Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prokinetic Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Prokinetic Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Prokinetic Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prokinetic Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prokinetic Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Prokinetic Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Prokinetic Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Prokinetic Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Prokinetic Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prokinetic Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prokinetic Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Prokinetic Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Prokinetic Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prokinetic Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Sumitomo Company Information
 Table 71. Sumitomo Description and Business Overview
 Table 72. Sumitomo Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sumitomo Prokinetic Drug Product
 Table 74. Sumitomo Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Prokinetic Drug Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Prokinetic Drug Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Kyowa Kirin Pharmaceuticals Company Information
 Table 86. Kyowa Kirin Pharmaceuticals Description and Business Overview
 Table 87. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product
 Table 89. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Prokinetic Drug Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Teva Company Information
 Table 96. Teva Description and Business Overview
 Table 97. Teva Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Prokinetic Drug Product
 Table 99. Teva Recent Developments/Updates
 Table 100. Cadila Pharmaceuticals Company Information
 Table 101. Cadila Pharmaceuticals Description and Business Overview
 Table 102. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cadila Pharmaceuticals Prokinetic Drug Product
 Table 104. Cadila Pharmaceuticals Recent Developments/Updates
 Table 105. Hanmi Pharm Company Information
 Table 106. Hanmi Pharm Description and Business Overview
 Table 107. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hanmi Pharm Prokinetic Drug Product
 Table 109. Hanmi Pharm Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Prokinetic Drug Distributors List
 Table 113. Prokinetic Drug Customers List
 Table 114. Prokinetic Drug Market Trends
 Table 115. Prokinetic Drug Market Drivers
 Table 116. Prokinetic Drug Market Challenges
 Table 117. Prokinetic Drug Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prokinetic Drug
 Figure 2. Global Prokinetic Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prokinetic Drug Market Share by Type: 2024 & 2031
 Figure 4. Metoclopramide Product Picture
 Figure 5. Domperidone Product Picture
 Figure 6. Cisapride Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Prokinetic Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Prokinetic Drug Market Share by Application: 2024 & 2031
 Figure 10. Gastroparesis
 Figure 11. Constipation
 Figure 12. Reflux Esophagitis
 Figure 13. Functional Dyspepsia
 Figure 14. Global Prokinetic Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Prokinetic Drug Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Prokinetic Drug Sales (2020-2031) & (K Units)
 Figure 17. Global Prokinetic Drug Average Price (US$/Unit) & (2020-2031)
 Figure 18. Prokinetic Drug Report Years Considered
 Figure 19. Prokinetic Drug Sales Share by Manufacturers in 2024
 Figure 20. Global Prokinetic Drug Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Prokinetic Drug Players: Market Share by Revenue in Prokinetic Drug in 2024
 Figure 22. Prokinetic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Prokinetic Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Prokinetic Drug Sales Market Share by Country (2020-2031)
 Figure 25. North America Prokinetic Drug Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Prokinetic Drug Sales Market Share by Country (2020-2031)
 Figure 29. Europe Prokinetic Drug Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Prokinetic Drug Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Prokinetic Drug Revenue Market Share by Region (2020-2031)
 Figure 37. China Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Prokinetic Drug Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Prokinetic Drug Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Prokinetic Drug Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Prokinetic Drug Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Prokinetic Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Prokinetic Drug by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Prokinetic Drug by Type (2020-2031)
 Figure 59. Global Prokinetic Drug Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Prokinetic Drug by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Prokinetic Drug by Application (2020-2031)
 Figure 62. Global Prokinetic Drug Price (US$/Unit) by Application (2020-2031)
 Figure 63. Prokinetic Drug Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Gastric Motility Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroparesis Treatment Products Market Insights Forecast to 2030
Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030
Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Bromopride Market Research Report 2024
Global Mosapride Market Research Report 2024
Gastroparesis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastroparesis Treatment Market Research Report 2024
Global Gastric Antisecretory Drug Market Insights Forecast to 2030
Global Digestive Drugs Market Insights Forecast to 2030
Gastrointestinal Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastroesophageal Reflux Drugs Market
Gastrointestinal Disorder Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gastrointestinal Therapeutics Market Research Report 2024
Gastrointestinal Bleeding Therapeutic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Treatment for Gastroparesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cinitapride Market Insights Forecast to 2030
Positive Inotropic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Proton Pump Inhibitor Drug Market Research Report 2025
Global Weight Loss Stomach Pump Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions